Search Press releases Keywords From To 2 Oct 2020 Disposals of own shares Read More 2 Oct 2020 Changes in UCB's Board of Directors Read More 25 Sep 2020 Disposals of own shares Read More 22 Sep 2020 UCB Achieves Important Regulatory Milestone for Bimekizumab Read More 11 Sep 2020 Disposals of own shares Read More 9 Sep 2020 Final Phase II Results for UCB’s Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances Read More Pagination First page Previous page Previous … Page 42 Page 43 Page 44 Page 45 Current page 46 Page 47 Page 48 Page 49 Page 50 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
